- CHARLOTTE, N.C. , Nov. 5, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the third quarter ended September 30, 2025., Third Quarter, , 2025 and Recent Highlights, (Unless otherwise stated, all percentage changes represent year-over-year comparisons), Net sales of $1.3 billion, including volume growth in Energy Storage (+8%) and Ketjen (+8%). Net loss of ($161) million, or ($1.72) per diluted share attributable to common shareholders; Adjusted loss of ($0.19) per diluted share attributable to common shareholders excludes a non-cash goodwill impairment charge associated with Ketjen. Adjusted EBITDA of $226 million; up 7% due to improved fixed…, Third Quarter 2025 Results, In millions, except per share amounts, , Q3 2025, , Q3 2024, , $ Change, , % Change, Net sales $ 1,307.8 $ 1,354.7 $ (46.9) (3.5) % Net loss attributable to Albemarle Corporation $ (160.7) $ (1,069.0) $ 908.3 85.0 % Adjusted EBITDA (b) $ 225.6 $ 211.5 $ 14.1 6.7 % Diluted loss per share attributable to common shareholders $ (1.72) $ (9.45) $ 7.73 81.8 % Non-recurring and other unusual…, Energy Storage Results, In millions, , Q3 2025, , Q3 2024, , $ Change, , % Change, Net Sales $ 708.8 $ 767.3 $ (58.5) (7.6) % Adjusted EBITDA $ 124.1 $ 142.9 $ (18.8) (13.2) % Energy Storage net sales for the third quarter of 2025 were $709 million, a decrease of $59 million, or 8%, due to lower pricing (-16%). Volumes were up 8% due to higher spodumene sales, record production from our integrated…, Specialties Results, In millions, , Q3 2025, , Q3 2024, , $ Change, , % Change, Net Sales $ 345.0 $ 342.4 $ 2.6 0.8 % Adjusted EBITDA $ 75.5 $ 56.3 $ 19.3 34.2 % Specialties net sales for the third quarter of 2025 were $345 million, an increase of $3 million, or 1%, as foreign exchange benefits offset slightly lower volumes (-1%) due to strength in demand for flame retardants in electrical…, Ketjen Results, In millions, , Q3 2025, , Q3 2024, , $ Change, , % Change, Net Sales $ 254.1 $ 245.0 $ 9.1 3.7 % Adjusted EBITDA $ 33.6 $ 35.5 $ (1.9) (5.4) % Ketjen net sales for the third quarter of 2025 were $254 million, up 4% compared to the prior-year quarter as higher volumes (+8%) were partially offset by lower prices (-5%). Adjusted EBITDA of $34 million decreased $2 million…, 2025 Outlook Considerations, Total Corporate Outlook Considerations, Albemarle is enhancing its prior full-year outlook considerations for the enterprise and Energy Storage, which are based on observed lithium market price scenarios. Full-year 2025 results are expected to be towards the higher end of the previously published $9/kg scenario ranges given year-to-date financial performance and lithium market pricing and better-than-expected Energy Storage volumes.…, Total Corporate FY 2025E , Including Energy Storage Scenarios, Observed market price case (a) H1 2025 average H1 2024 range Q4 2023 average Average lithium market price ($/kg LCE) (a) ~$9 $12-15 ~$20 Net sales $4.9 - $5.2 billion $5.3 - $6.1 billion $6.5 - $7.0 billion Adjusted EBITDA (b) $0.8 - $1.0 billion $1.2 - $1.8 billion $2.5 - $2.7 billion (a) Price represents blend of relevant market pricing including spot and regional indices for the periods…, Energy Storage Market Price Scenarios, , Energy Storage FY 2025E , Observed market price case (a) H1 2025 average H1 2024 range Q4 2023 average Average lithium market price ($/kg LCE) (a) ~$9 $12-15 ~$20 Net sales $2.5 - $2.6 billion $2.9 - $3.5 billion $4.2 - $4.5 billion Adjusted EBITDA $0.6 - $0.7 billion $1.0 - $1.5 billion $2.2 - $2.4 billion Equity in net income of unconsolidated investments (net of tax) (b) $0.2 - $0.3 billion $0.3 - $0.5 billion $0.6 - $…, Specialties and Ketjen Outlook Considerations, Specialties outlook reflects volume growth in key end markets led by pharma, automotive and oilfield, partially offset by weakness in building and construction. Ketjen outlook assumes strong fluidized catalytic cracking (FCC) volume offset by lower clean fuel technologies (CFT) volume due to order timing. , Segment FY 2025E, Specialties net sales $1.3 - $1.5 billion Specialties adjusted EBITDA $210 - $280 million Ketjen net sales $1.0 - $1.1 billion Ketjen adjusted EBITDA $120 - $150 million , Other Corporate Outlook Considerations, Albemarle expects its 2025 capital expenditures to be approximately $600 million, down 65% from $1.7 billion in 2024. This level of spending reflects in part a timing impact and a continued prioritization on sustaining existing assets and resources. Reduced corporate costs reflect cost savings and foreign exchange gains to date. , Other Corporate FY 2025E , Capital expenditures ~$600 million Depreciation and amortization $630 - $670 million Adjusted effective tax rate (a) (40)% - 25% Corporate costs (b) $10 - $30 million Interest and financing expenses $180 - $210 million Weighted-average common shares outstanding (diluted) 118 million (a) Adjusted effective tax rate dependent on lithium market prices and geographic income mix (b) FY 2025E…, Cash Flow and Capital Deployment, Cash from operations of $894 million in the first nine months of 2025 increased $202 million compared to the prior-year period due to cost and productivity improvements, cash management actions and a customer prepayment received in January. We now expect to achieve positive free cash flow of approximately $300 to $400 million for the full year 2025 given year-to-date financial performance and…, Balance Sheet and Liquidity, As of September 30, 2025, Albemarle had estimated liquidity of approximately $3.5 billion, including $1.9 billion of cash and cash equivalents, $1.5 billion available under our revolver and $107 million available under other credit lines. Total debt was $3.6 billion, representing a net debt to adjusted EBITDA ratio (as defined in our credit agreement) of approximately 2.1 times. In the fourth…, Earnings Call, Date: Thurs., November 6, 2025 Time: 8:00 AM Eastern time Dial-in (U.S.): 1-800-590-8290 Dial-in (International): 1-240-690-8800 Conference ID: ALBQ3 The company's earnings presentation and supporting material are available on Albemarle's website at https://investors.albemarle.com ., About Albemarle, Albemarle Corporation (NYSE: ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to pioneer new ways to move, power, connect and protect with people and planet in mind. A reliable and high-quality global supply of lithium and bromine allows us to deliver advanced solutions for our customers. Learn more about…, Forward-Looking Statements, This press release contains statements concerning our expectations, anticipations and beliefs regarding the future, which constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and…, Three Months Ended, , Nine Months Ended, , September 30,, , September 30,, , 2025, , 2024, , 2025, , 2024, Net sales $ 1,307,829 $ 1,354,692 $ 3,714,702 $ 4,145,813 Cost of goods sold 1,190,219 1,458,726 3,243,917 4,221,487 Gross profit (loss) 117,610 (104,034) 470,785 (75,674) Selling, general and administrative expenses 138,577 154,253 394,536 482,052 Goodwill impairment charges 181,070 — 181,070 — Restructuring charges and asset write-offs 2,275 828,146 5,660 1…, September 30,, , December 31,, , 2025, , 2024, , ASSETS, Current assets: Cash and cash equivalents $ 1,931,758 $ 1,192,230 Trade accounts receivable 733,477 742,201 Other accounts receivable 107,701 238,384 Inventories 1,532,622 1,502,531 Other current assets 249,347 166,916 Total current assets 4,554,905 3,842,262 Property, plant and equipment 12,902,998 12,523,368 Less accumulated depreciation and…, LIABILITIES AND EQUITY, Current liabilities: Accounts payable to third parties $ 780,377 $ 793,455 Accounts payable to related parties 122,794 150,432 Accrued expenses 500,940 467,997 Current portion of long-term debt 445,384 398,023 Dividends payable 61,339 61,282 Income taxes payable 93,120 95,275 Total current liabilities 2,003,954 1,966,464 Long-term debt 3,181,009…, Nine Months Ended, , September 30,, , 2025, , 2024, Cash and cash equivalents at beginning of year $ 1,192,230 $ 889,900 Cash flows from operating activities: Net loss (63,450) (1,220,588) Adjustments to reconcile net loss to cash flows from operating activities: Depreciation and amortization 494,968 425,532 Non-cash goodwill impairment charges 181,070 — Non-cash restructuring and asset write-offs — 1,075,888 Stock-…, Three Months Ended, , Nine Months Ended, , September 30,, , September 30,, , 2025, , 2024, , 2025, , 2024, , Net sales:, Energy Storage $ 708,755 $ 767,291 $ 1,950,976 $ 2,398,299 Specialties 344,960 342,376 1,017,534 993,041 Ketjen 254,114 245,025 746,192 754,473 Total net sales $ 1,307,829 $ 1,354,692 $ 3,714,702 $ 4,145,813 , Adjusted EBITDA:, Energy Storage $ 124,077 $ 142,887 $ 530,157 $ 623,862 Specialties 75,544 56,273 207,187 155,629 Ketjen 33,566 35,473 100,721 95,288 Total segment adjusted EBITDA 233,187 234,633 838,065 874,779 Corporate (7,557) (23,135) (8,816) 14,315 Total adjusted EBITDA $ 225,630 $ 211,498 $ 829,249 $ 889,094 See accompanying non-GAAP…, Additional Information Regarding Non-GAAP Measures, It should be noted that adjusted net income (loss) attributable to Albemarle Corporation, adjusted net loss attributable to Albemarle Corporation common shareholders, adjusted diluted loss per share attributable to common shareholders, non-operating pension and other post-employment benefit ("OPEB") items per diluted share, non-recurring and other unusual items per diluted share, adjusted…, ALBEMARLE CORPORATION AND SUBSIDIARIES, Non-GAAP Reconciliations, (Unaudited), See below for a reconciliation of adjusted net income (loss) attributable to Albemarle Corporation, adjusted net loss attributable to Albemarle Corporation common shareholders, EBITDA and adjusted EBITDA (on a consolidated basis), which are non-GAAP financial measures, to Net loss attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in…, Three Months Ended, , Nine Months Ended, , September 30,, , September 30,, , 2025, , 2024, , 2025, , 2024, , In thousands, except percentages and per share amounts, , $, , % of net sales, , $, , % of net sales, , $, , % of net sales, , $, , % of net sales, Net loss attributable to Albemarle Corporation ($160,694) $ (1,068,992) ($96,449) $ (1,254,742) Add back: Non-operating pension and OPEB items (net of tax) 189 (344) 483 (1,031) Non-recurring and other unusual items (net of tax) 180,025 928,771 190,533 1,203,313 Adjusted net income (loss)…, EBITDA, 24,183 1.8 % (746,877) (55.1) % 547,945 14.8 % (631,822) (15.2) % Proportionate share of Windfield income tax expense 20,023 1.5 % 99,523 7.3 % 78,499 2.1 % 292,992 7.1 % Non-operating pension and OPEB items 367 — % (331) — % 978 — % (993) — % Non-recurring and other unusual items 181,057 13.8 % 859,183 63.4 % 201,827 5.4 % 1,228,917 29.6 %, Adjusted EBITDA, $225,630 17.3 % $ 211,498 15.6 % $ 829,249 22.3 % $ 889,094 21.4 % Net sales $ 1,307,829 $ 1,354,692 $ 3,714,702 $ 4,145,813 Non-operating pension and OPEB items, consisting of mark-to-market actuarial gains/losses, settlements/curtailments, interest cost and expected return on assets, are not allocated to…, Three Months Ended, , Nine Months Ended, , September 30,, , September 30,, , 2025, , 2024, , 2025, , 2024, Interest cost $ 8,976 $ 8,523 $ 26,710 $ 25,529 Expected return on assets (8,609) (8,854) (25,732) (26,522) Total $ 367 $ (331) $ 978 $ (993) In addition to the non-operating pension and OPEB items disclosed above, the company has identified certain other items and excluded them from Albemarle's adjusted net (loss) income…, Three Months Ended, , Nine Months Ended, , September 30,, , September 30,, , 2025, , 2024, , 2025, , 2024, Restructuring charges and asset write-offs (1) $ 0.02 $ 7.91 $ 0.03 $ 9.99 Goodwill impairment charges (2) 1.49 — 1.49 — Acquisition and integration related costs (3) 0.01 — 0.03 0.03 (Gain) loss in fair value of public equity securities (4) (0.05) 0.03 (0.02) 0.50 Other (5) 0.03 (0.04) 0.07 (0.23) Tax related items (6) 0.03 — 0.…, Loss before income taxes and equity in net income of unconsolidated investments, , Income tax (benefit) expense, , Effective income tax rate, , Three months ended September 30, 2025, As reported $ (239,146) $ (30,565) 12.8 % Non-recurring, other unusual and non-operating pension and OPEB items 181,424 1,210 As adjusted $ (57,722) $ (29,355) 50.9 % , Three months ended September 30, 2024, As reported $ (1,178,846) $ 110,853 (9.4) % Non-recurring, other unusual and non-operating pension and OPEB items 858,852 (69,575) As adjusted $ (319,994) $ 41,278 (12.9) % , Nine months ended September 30, 2025, As reported $ (267,083) $ (449) 0.2 % Non-recurring, other unusual and non-operating pension and OPEB items 202,805 11,789 As adjusted $ (64,278) $ 11,340 (17.6) % , Nine months ended September 30, 2024, As reported $ (1,840,552) $ 76,472 (4.2) % Non-recurring, other unusual and non-operating pension and OPEB items 1,227,924 25,642 As adjusted $ (612,628) $ 102,114 (16.7) % , Albemarle Investor Relations Contact: +1 (980) 308-6194,, [email protected], View original content to download multimedia: https://www.prnewswire.com/news-releases/albemarle-reports-third-quarter-2025-results-302606047.html SOURCE Albemarle CorporationType: Article